Enveda Biosciences Funding & Investors
Boulder, CO
Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. Enveda, launched in 2019, is based in San Francisco, California.
envedabio.comTotal Amount Raised: $229,900,000
Enveda Biosciences Funding Rounds
Series B
$55,000,000
Series B Investors
LingottoTrue VenturesMicrosoftFPV VenturesLevel VenturesPremjiInvestJazz Venture PartnersThe Nature ConservancyKinnevikSeries B
$51,000,000
Series B Investors
KinnevikTrue VenturesWireframe VenturesFPV VenturesDimensionHenry KravisSeries B
$55,000,000
Series B Investors
DimensionFPV VenturesJazz Venture PartnersAmino CollectiveTrue VenturesAllen & CompanyLevel VenturesLux CapitalPossible VenturesHummingbird VenturesWireframe VenturesTwo Sigma VenturesDebt Financing
$13,000,000
Debt Financing Investors
Silicon Valley Bank (SVB)Series A
$51,000,000
Series A Investors
Lux CapitalCatalio Capital ManagementWireframe VenturesTrue VenturesHummingbird VenturesChris GibsonLifeforce CapitalTwo Sigma VenturesVillage GlobalMatt De SilvaBiovergeSeed
$4,900,000
Seed Investors
True VenturesVillage GlobalChris GibsonWireframe Ventures